EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C11H17N3O |
| Net Charge | 0 |
| Average Mass | 207.277 |
| Monoisotopic Mass | 207.13716 |
| SMILES | CCC/C=C/C/C=C/C=C/C=N/NN=O |
| InChI | InChI=1S/C11H17N3O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15/h4-5,7-11H,2-3,6H2,1H3,(H,13,15)/b5-4+,8-7+,10-9+,12-11+ |
| InChIKey | NKTGCVUIESDXPU-YLEPRARLSA-N |
| Wikipedia |
|---|
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Streptomyces aureofaciens (ncbitaxon:1894) | cell suspension culture (BTO:0000221) | PubMed (6804425) | Strain: 1228 |
| Roles Classification |
|---|
| Biological Roles: | EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor An EC 6.2.1.* (acid-thiol ligase) inhibitor that interferes with the action of a long-chain-fatty-acid—CoA ligase (EC 6.2.1.3). apoptosis inhibitor Any substance that inhibits the process of apoptosis (programmed cell death) in multi-celled organisms. bacterial metabolite Any prokaryotic metabolite produced during a metabolic reaction in bacteria. antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. EC 3.1.1.64 (retinoid isomerohydrolase) inhibitor An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of retinoid isomerohydrolase (EC 3.1.1.64). |
| Applications: | antimalarial A drug used in the treatment of malaria. Antimalarials are usually classified on the basis of their action against Plasmodia at different stages in their life cycle in the human. vasodilator agent A drug used to cause dilation of the blood vessels. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| triacsin C (CHEBI:144441) has role antimalarial (CHEBI:38068) |
| triacsin C (CHEBI:144441) has role apoptosis inhibitor (CHEBI:68494) |
| triacsin C (CHEBI:144441) has role bacterial metabolite (CHEBI:76969) |
| triacsin C (CHEBI:144441) has role EC 3.1.1.64 (retinoid isomerohydrolase) inhibitor (CHEBI:144455) |
| triacsin C (CHEBI:144441) has role EC 6.2.1.3 (long-chain-fatty-acid—CoA ligase) inhibitor (CHEBI:83157) |
| triacsin C (CHEBI:144441) has role vasodilator agent (CHEBI:35620) |
| triacsin C (CHEBI:144441) is a hydrazone (CHEBI:38532) |
| triacsin C (CHEBI:144441) is a nitroso compound (CHEBI:35800) |
| triacsin C (CHEBI:144441) is a olefinic compound (CHEBI:78840) |
| IUPAC Name |
|---|
| N-[(1E,2E,4E,7E)-undeca-2,4,7-trien-1-ylidene]nitrous hydrazide |
| Synonyms | Source |
|---|---|
| WS 1228A | ChemIDplus |
| FR 900190 | ChemIDplus |
| nitrosohydrazone-2E,4E,7E-undecatrienal | ChEBI |
| WS-1228A | ChEBI |
| 2,4,7-undecatrienal nitrosohydrazone | ChEBI |
| (2E,4E,7E)-2,4,7-undecatrienal nitrosohydrazone | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Triacsin_C | Wikipedia |
| CPD-14770 | MetaCyc |
| LSM-43284 | LINCS |
| Registry Numbers | Sources |
|---|---|
| CAS:76896-80-5 | ChemIDplus |
| Citations |
|---|